Showing results (61-70 of 164) with videos related to
Sort By:
Pageof 17
Aquatic Toxicology (Amsterdam, Netherlands)|December 11, 2025
Size-dependent and tissue specific accumulation of polystyrene microplastics and nanoplastics in zebrafishMin Su, Dangen Gu, Le Liang, et al.Asian Journal of Andrology|February 10, 2026
Multidimensional explanations and future perspectives on the limited efficacy of immunotherapy in prostate cancerShan-Shan Fan, Yi-Min Chen, Wen-Da Chen, et al.Frontiers in Cellular and Infection Microbiology|July 16, 2026
Single-cell reanalysis identifies macrophage-associated transcriptional and intercellular communication features in diabetic foot ulcersJia Yao, Chang-Qing Zhu, Xue-Jian Deng, et al.Medicine|June 7, 2019
Base excess in predicting the prognosis of patients with paraquat poisoning: A meta-analysisFeng Wei Zhang, Jie Gao, Su Li Zhang, et al.ACS Applied Materials & Interfaces|May 30, 2017
Self-Assembled Graphene Film as Low Friction Solid Lubricant in Macroscale ContactPu Wu, Xinming Li, Chenhui Zhang, et al.American Journal of Cancer Research|February 18, 2020
MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugsChung-Pu Wu, Sabrina Lusvarghi, Pin-Jung Tseng, et al.Journal of Bioscience and Bioengineering|August 19, 2007
Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice modelQian Shen, Qiang Sun, Xiaoluan Wei, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 21, 2025
The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugsYen-Ching Li, Bing-Huan Lin, Megumi Murakami, et al.Frontiers in Immunology|July 16, 2024
Causality of immune cells on primary sclerosing cholangitis: a bidirectional two-sample Mendelian randomization studyPu Wu, Sinan Xie, Yunshi Cai, et al.The Journal of Pharmacy and Pharmacology|March 16, 2026
Befotertinib restored chemosensitivity to multidrug-resistant cancer cells by inhibiting the drug efflux activity of ABCB1Yen-Ching Li, Megumi Murakami, Yang-Hui Huang, et al.Pageof 17